A Comparison of Clinical Features between Community-Associated and Healthcare-Associated Methicillin-Resistant Staphylococcus aureus Keratitis

Table 5

Treatment and clinical outcome of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) and healthcare-associated methicillin-resistant Staphylococcus aureus (HA-MRSA) keratitis.

	CA-MRSA (); (%)	HA-MRSA (); (%)	value
Modification of antibiotics: (%)	9 (81.8)	8 (61.5)	.386^*
Surgical intervention: (%)	5 (41.7)	4 (28.6)	.683^*
Admission: (%)	8 (66.7)	5 (35.7)	.253^*
Severe complication^†: (%)	3 (25)	1 (7.1)	.306^*
Complete remission^‡ (months): median (mini~max)	1.335 (0.2~8.2)	0.93 (0.2~8.5)	.348
VA (logMAR)^#: median (mini~max)
Initial	3 (0~3)	3 (0~3)	.331
Final	1.7 (0~3.2)	3 (0.4~3.2)	.282

Mann-Whitney test was used for comparison of VA and complete remission and chi-square test for others.
^*P value obtained by Fisher's exact test.
^†Severe complication: corneal perforation and/or endophthalmitis.
^‡Complete remission: defined as the resolution of infiltration and epithelial defect.
^#VA: visual acuity, recorded using Snellen letter charts. If data were available, Snellen VA was converted to logarithm of the minimum angle (logMAR).